Cefmenoxime FDA Link

A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.

Also Known As:

Cefmax; Abbott-50192; Cefmenoxime Hydrochloride; Cefmenoxime Hydrochloride (2:1); SCE-1365; Abbott 50192; Abbott50192; Hydrochloride, Cefmenoxime; SCE 1365; SCE1365; 5- Thia- 1- azabicyclo(4.2.0)oct- 2- ene- 2- carboxylic acid, 7- (((2- amino- 4- thiazolyl)(methoxyimino)acetyl)amino)- 3- (((1- methyl- 1H- tetrazol- 5- yl)thio)methyl)- 8- oxo- , (6R-(6alpha,7beta(Z)))-

Pharmalogical Action Categories:

Anti-Bacterial Agents

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        Cephacetrile: 28
        Cefotaxime: 1712
        Cefmenoxime: 129
- Sulfur Compounds: 278
  - Thiazines: 3
    - Cephalosporins: 4007
      - Cephacetrile: 28
        Cefotaxime: 1712
        Cefmenoxime: 129
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        Cephacetrile: 28
        Cefotaxime: 1712
        Cefmenoxime: 129

Cefmenoxime Products